This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Romana SP, Poirel H, Leconiat M-Y, Flexor M, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA . High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia Blood 1995 86: 4263–4269
McLean TW, Ringold S, Neuberg D, Stegmeier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JWG, Seriu T, Bartram CR, Sallan SE, Gilliland GD, Golub TR . Tel/Aml1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia Blood 1996 88: 4252–4258
Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F . Incidence of Tel/Aml1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse Blood 1997 90: 4933–4937
Bièche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M . Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications Clin Chem 1999 45: 1148–1156
Acknowledgements
This work was supported by a grant from the Direction de la Recherche Clinique de l'Assistance Publique-Hôpitaux de Paris (AP-HP), Projet TBI 97-297, France (PB).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ballerini, P., Landman Parker, J., Laurendeau, I. et al. Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia. Leukemia 14, 1526–1528 (2000). https://doi.org/10.1038/sj.leu.2401858
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401858
This article is cited by
-
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects
Leukemia (2003)
-
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
Leukemia (2003)
-
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program
Leukemia (2003)
-
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR
Leukemia (2002)